AHFS October 2022 Update

This update contains 2 new monographs and 23 revised monographs.

New monographs: COVID-19 Vaccine (Novavax); Roflumilast (Topical).

Revised monographs: Alemtuzumab (MS); Bebtelovimab; Dasiglucagon; Dimethyl Fumarate; Diroximel Fumarate; Fingolimod Hydrochloride; Gefitinib; Glatiramer Acetate; Glucagon; Glycopyrronium tosylate; Maribavir; Monomethyl Fumarate; Natalizumab; Nirmatrelvir and Ritonavir; Odevixibat; Ofatumumab (Multiple Sclerosis); Osilodrostat Phosphate; Ozanimod Hydrochloride; Ponesimod; Ruxolitinib Phosphate (Topical); Sofosbuvir and Velpatasvir; Tildrakizumab-asmn; Vismodegib.